9 Common Physical Changes From Metastatic Breast Cancer and How to Cope
Medically reviewed by Aleesha Grier, PsyD Metastatic breast cancer affects people in many ways. The symptoms experienced by each person will vary based on the parts of the body that are affected. Some symptoms are a result of the cancer,
8 Ways to Combat Isolation With a Metastatic Breast Cancer Diagnosis
Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ways to cope without isolating. Here's how.
BriaCell immunotherapy destroys metastatic breast cancer tumor
BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS candidate is now cancer-free in the lungs ・Bria-OTS is a personalized off-the-shelf cancer immunotherapy ・BriaCell is a clinical-stage biotechnology stock developing immunotherapies to transform cancer care ・BriaCell stock is up
BriaCell Therapeutics Drops 4% Following Metastatic Breast Cancer Trial Results
BriaCell Therapeutics Corp. (BCTX, BCTXW) is down by 4.71 percent during Monday morning trading, following the announcement of a
T-DXd Reevaluated in HER2-Low/HER2-Negative Breast Cancer After New Trials
During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast cancer and the need for HER2-negative data with T-DXd.
BriaCell Therapeutics stock rises on positive clinical trial results
Shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX) climbed 10% following the announcement of a significant clinical response in the first patient treated with Bria-OTS, the company's novel immunotherapy for metastatic breast cancer.
Pharm Exec5h
FDA Approves Expanded Label for Roche's Companion Diagnostic to Identify HER2-Ultralow Breast Cancer Patients Eligible for Enhertu
The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...
FDA approval expands earlier use of Enhertu for metastatic breast cancer
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
MedPage Today4d
Time to Reconsider MRI to Detect Asymptomatic Brain Mets in Breast Cancer?
The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
FierceBiotech4h
Roche’s Enhertu companion diagnostic secures new FDA approval in HER2-ultralow breast cancer
Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...
Metastatic Breast Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight
DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...
Cure Today7d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
Science Daily13d
Breast Cancer News
Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™
Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...